Cefaclor

头孢克洛

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameCefaclor
Drug Alias Name头孢克罗Cefaclorum头孢氯氨苄氯头孢菌素氯氨苄青霉素 +[12] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsCoronary DiseaseNephritisPeriodontitis +[7] 
Global Approved IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial InfectionsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1978/08/21
Country/TerritoryCanadaUnited StatesUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesFlynn Pharma Ltd
Inactive CompaniesEli Lilly And Company
Active IndicationsCoronary DiseaseNephritisPeriodontitis +[5] 
Inactive IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeJ01DC04
Related LinksWikipediaDrugBankKEGG